Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 3
2005 1
2007 1
2008 3
2010 3
2011 5
2012 5
2013 5
2014 2
2016 6
2017 1
2018 3
2019 3
2020 8
2021 7
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.
Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, Zhang W, Hsu CH, He AR, Ryoo BY, Yau T, Kaseb AO, Burgoyne AM, Dayyani F, Spahn J, Verret W, Finn RS, Toh HC, Lujambio A, Wang Y. Zhu AX, et al. Among authors: dayyani f. Nat Med. 2022 Aug;28(8):1599-1611. doi: 10.1038/s41591-022-01868-2. Epub 2022 Jun 23. Nat Med. 2022. PMID: 35739268
Immunotherapy Updates in Advanced Hepatocellular Carcinoma.
Singh A, Beechinor RJ, Huynh JC, Li D, Dayyani F, Valerin JB, Hendifar A, Gong J, Cho M. Singh A, et al. Among authors: dayyani f. Cancers (Basel). 2021 Apr 30;13(9):2164. doi: 10.3390/cancers13092164. Cancers (Basel). 2021. PMID: 33946408 Free PMC article. Review.
Therapy in Advanced Hepatocellular Carcinoma.
Javan H, Dayyani F, Abi-Jaoudeh N. Javan H, et al. Among authors: dayyani f. Semin Intervent Radiol. 2020 Dec;37(5):466-474. doi: 10.1055/s-0040-1719187. Epub 2020 Dec 11. Semin Intervent Radiol. 2020. PMID: 33328702 Free PMC article. Review.
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer.
Brendel K, Bekaii-Saab T, Boland PM, Dayyani F, Dean A, Macarulla T, Maxwell F, Mody K, Pedret-Dunn A, Wainberg ZA, Zhang B. Brendel K, et al. Among authors: dayyani f. CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1550-1563. doi: 10.1002/psp4.12725. Epub 2021 Nov 20. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34750990 Free PMC article. Clinical Trial.
HIV-associated multicentric Castleman's disease.
Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ. Stebbing J, et al. Among authors: dayyani f. Am J Hematol. 2008 Jun;83(6):498-503. doi: 10.1002/ajh.21137. Am J Hematol. 2008. PMID: 18260115 Free article. Review.
Management of advanced primary urethral carcinomas.
Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Dayyani F, et al. BJU Int. 2014 Jul;114(1):25-31. doi: 10.1111/bju.12630. Epub 2014 May 22. BJU Int. 2014. PMID: 24447439 Review.
Clinically Meaningful Use of Blood Tumor Markers in Oncology.
Holdenrieder S, Pagliaro L, Morgenstern D, Dayyani F. Holdenrieder S, et al. Among authors: dayyani f. Biomed Res Int. 2016;2016:9795269. doi: 10.1155/2016/9795269. Epub 2016 Nov 30. Biomed Res Int. 2016. PMID: 28042579 Free PMC article. Review.
72 results